当前位置:首页 - 行情中心 - 伟思医疗(688580) - 财务分析 - 现金流量表

伟思医疗

(688580)

  

流通市值:61.54亿  总市值:61.54亿
流通股本:9577.13万   总股本:9577.13万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金115,221,492.03526,018,082.02366,019,861.6236,082,962.93
  收到的税费返还2,574,060.4317,392,902.1613,420,143.328,203,831.73
  收到其他与经营活动有关的现金4,079,852.5811,905,357.3410,738,740.269,615,078.06
  经营活动现金流入小计121,875,405.04555,316,341.52390,178,745.18253,901,872.72
  购买商品、接受劳务支付的现金36,153,584.27134,203,067.8696,804,106.5461,510,302.03
  支付给职工以及为职工支付的现金48,699,452.07138,100,523.52108,426,858.9475,991,713.22
  支付的各项税费12,540,395.7653,076,975.4240,509,905.2929,099,421.97
  支付其他与经营活动有关的现金8,588,188.3653,191,465.0640,031,622.9722,515,471.79
  经营活动现金流出小计105,981,620.46378,572,031.86285,772,493.74189,116,909.01
  经营活动产生的现金流量净额15,893,784.58176,744,309.66104,406,251.4464,784,963.71
二、投资活动产生的现金流量:
  收回投资收到的现金866,000,0003,521,040,327.162,591,000,0001,681,000,000
  取得投资收益收到的现金2,550,983.4212,533,301.19,763,745.786,593,169.16
  处置固定资产、无形资产和其他长期资产收回的现金净额71,342,00041,650,389.38440440
  收到的其他与投资活动有关的现金-1,200,0001,761,0001,200,000
  投资活动现金流入小计939,892,983.423,576,424,017.642,602,525,185.781,688,793,609.16
  购建固定资产、无形资产和其他长期资产支付的现金80,726,075.25118,117,619.2586,592,384.9254,350,575.53
  投资支付的现金1,166,000,0003,571,000,0002,591,000,0001,681,000,000
  取得子公司及其他营业单位支付的现金-29,648,485--
  支付其他与投资活动有关的现金900,0001,150,0001,150,0001,000,000
  投资活动现金流出小计1,247,626,075.253,719,916,104.252,678,742,384.921,736,350,575.53
  投资活动产生的现金流量净额-307,733,091.83-143,492,086.61-76,217,199.14-47,556,966.37
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-76,569,346.477,571,632.1477,237,024.02
  支付其他与筹资活动有关的现金-877,282.9434,480.43146,162.66
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-77,446,629.378,006,112.5777,383,186.68
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--77,446,629.3-78,006,112.57-77,383,186.68
四、汇率变动对现金及现金等价物的影响-46,718.16-40,814.5514,187.894,022.12
五、现金及现金等价物净增加额-291,886,025.41-44,235,220.8-49,802,872.38-60,151,167.22
  加:期初现金及现金等价物余额1,022,971,611.931,067,206,832.731,067,206,832.731,067,206,832.73
  期末现金及现金等价物余额731,085,586.521,022,971,611.931,017,403,960.351,007,055,665.51
补充资料:
  净利润-138,072,645.5-69,324,242.51
  资产减值准备-430,627.75--
  固定资产和投资性房地产折旧-15,568,748.69-6,657,647.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,568,748.69-6,657,647.73
  无形资产摊销-10,974,095.14-7,894,032.23
  长期待摊费用摊销-1,322,287.81-626,434
  处置固定资产、无形资产和其他长期资产的损失-880.57-864.63
  公允价值变动损失--4,835,413.96--
  财务费用-1,308,051.09-701,883.15
  投资损失--12,533,301.1--6,593,169.16
  递延所得税--521,291.88--526,161.52
  其中:递延所得税资产减少--455,252.01--493,173.02
    递延所得税负债增加--66,039.87--32,988.5
  存货的减少--3,900,453.44--2,810,874.76
  经营性应收项目的减少--35,595,255.84--1,694,589.33
  经营性应付项目的增加-61,707,447.05--9,706,372.4
  其他-2,481,992.42--
  不涉及现金收支的投资和筹资活动金额其他项目-159,008.79-7,321.95
  现金的期末余额-1,022,971,611.93-1,007,055,665.51
  减:现金的期初余额-1,067,206,832.73-1,067,206,832.73
  现金及现金等价物的净增加额--44,235,220.8--60,151,167.22
公告日期2026-04-282026-04-282025-10-232025-08-28
审计意见(境内)标准无保留意见
TOP↑